Post partum haemorrhage on a mother baby unit at 12 hours post delivery - Nursing Case Study

Pathophysiology

• Primary mechanism: Uterine atony is the most common cause of postpartum hemorrhage, where the uterus fails to contract effectively after delivery. This lack of contraction prevents the compression of blood vessels at the placental site, leading to excessive bleeding.

• Secondary mechanism: Retained placental tissue can also contribute to postpartum hemorrhage. Remaining fragments of the placenta impede proper uterine contraction and cause continued bleeding as the uterine vessels remain open.

• Key complication: Both mechanisms can lead to hypovolemic shock if not promptly addressed, characterized by decreased blood volume, reduced perfusion to vital organs, and potential for multi-organ failure, necessitating immediate intervention to stabilize the mother.

Patient Profile

Demographics:

32-year-old female, nurse

History:

• Key past medical history: Previous cesarean section, gestational diabetes, anemia

• Current medications: Prenatal vitamins, insulin (for gestational diabetes), iron supplements

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe bleeding and weakness 12 hours post delivery

• Key symptoms: Heavy vaginal bleeding, dizziness, shortness of breath, palpitations

• Vital signs: Blood pressure 80/50 mmHg, heart rate 130 bpm, respiratory rate 28 breaths per minute, temperature 36.5°C, oxygen saturation 89% on room air

Section 1

As the healthcare team swiftly initiates interventions to address the postpartum hemorrhage, an initial assessment reveals alarming findings. The uterine fundus is palpated and found to be boggy and displaced, indicating inadequate uterine contraction. Despite external uterine massage and administration of oxytocin, there is minimal improvement in uterine tone. The patient's bleeding is profuse, soaking through pads rapidly, and clots are expelled with each contraction attempt. Her skin is pale and diaphoretic, and she exhibits signs of altered mental status, responding slowly to questions, which signals potential cerebral hypoperfusion.

The laboratory results return, painting a concerning picture of the patient's condition. Hemoglobin levels have dropped precipitously to 6.5 g/dL from a previous baseline of 11 g/dL, confirming significant blood loss. Her hematocrit is critically low at 20%, and the platelet count has decreased to 90,000/mm³, suggestive of a developing consumptive coagulopathy. Serum lactate levels are elevated at 4 mmol/L, indicating tissue hypoxia and suggesting that the patient is progressing towards hypovolemic shock. Blood gas analysis reflects a compensated metabolic acidosis, with a pH of 7.32 and bicarbonate levels at 18 mEq/L, further highlighting the severity of her condition.

In response to these findings, the care team must quickly escalate their interventions. The patient is urgently transferred to the intensive care unit for closer monitoring and aggressive resuscitation. Blood transfusions are initiated to restore circulating volume, and additional uterotonics are considered to address persistent uterine atony. Despite these efforts, the patient's status continues to be precarious, underscoring the need for further diagnostic imaging to rule out retained placental tissue or other sources of bleeding. The situation demands advanced critical thinking to navigate the complex interplay of interventions needed to stabilize the patient's rapidly deteriorating condition.

Section 2

As the team transitions the patient to the intensive care unit, her vital signs show alarming trends. Her heart rate has increased to 130 beats per minute, and her blood pressure has dropped further to 80/50 mmHg, despite the initiation of aggressive fluid resuscitation. Respiratory rate is elevated at 26 breaths per minute, compensating for her worsening metabolic acidosis. Oxygen saturation remains borderline at 92% on supplemental oxygen via a non-rebreather mask. The clinical picture suggests a progression towards more severe stages of hypovolemic shock, necessitating immediate and comprehensive intervention.

The decision is made to conduct a bedside ultrasound to evaluate for retained placental tissue or other sources of bleeding. The ultrasound reveals significant retained products of conception, contributing to the persistent uterine atony and ongoing hemorrhage. In light of these findings, the team prepares for an urgent dilation and curettage (D&C) procedure, aiming to remove the retained tissue and improve uterine contractility. Meanwhile, blood products are administered continuously, including packed red blood cells and fresh frozen plasma, to address her coagulopathy and support hemodynamic stability.

Despite these interventions, the patient's condition remains critical. Her mental status fluctuates, with moments of disorientation and lethargy, indicative of ongoing cerebral hypoperfusion. The team considers the possibility of disseminated intravascular coagulation (DIC) as a compounding factor, prompted by the low platelet count and prolonged bleeding time. Coagulation studies are expedited to confirm the diagnosis, and the patient is closely monitored for any signs of further deterioration. The complexity of the case demands precise coordination and rapid decision-making to stabilize the patient and avert further complications.

Section 3

As the clinical team continues to manage the patient in the intensive care unit, new diagnostic results emerge that further illuminate her precarious condition. The coagulation studies return, confirming the presence of disseminated intravascular coagulation (DIC), with markedly elevated D-dimer levels, prolonged prothrombin time (PT), and a significantly decreased fibrinogen level. These findings corroborate the clinical suspicion of DIC, exacerbating the patient's bleeding tendencies and complicating her hemodynamic management. Concurrently, a repeat complete blood count reveals a further drop in hemoglobin to 6.5 g/dL, despite ongoing transfusions, indicating that the bleeding has not been fully controlled and the patient remains in critical need of intervention.

In response to these findings, the medical team intensifies their efforts to stabilize the patient. Additional transfusions of cryoprecipitate and platelets are ordered to address the coagulopathy, and the decision is made to expedite the dilation and curettage (D&C) procedure to remove the retained placental tissue. During the procedure, the patient experiences a sudden drop in oxygen saturation to 85%, accompanied by increased respiratory distress, suggesting a potential complication such as pulmonary embolism or fluid overload. Arterial blood gas results confirm worsening metabolic acidosis with a pH of 7.25 and elevated lactate levels, indicating insufficient tissue perfusion and oxygenation.

The team quickly administers intravenous bicarbonate to address the acidosis while ensuring vigilant monitoring of the patient's cardiopulmonary status. The possibility of acute respiratory distress syndrome (ARDS) is considered, prompting the initiation of low-dose vasopressors to maintain perfusion pressures and support cardiac output. This multifaceted situation necessitates a careful balance of interventions, with the team anticipating potential complications such as multi-organ dysfunction. The focus remains on optimizing the patient's oxygen delivery, correcting coagulopathy, and achieving hemostatic control to ultimately guide her back to stability.

Section 4

Response to Interventions

As the medical team continues their coordinated efforts, the patient shows a partial response to the interventions. The administration of cryoprecipitate and platelets begins to stabilize the coagulation profile, with repeat labs showing a slight improvement in fibrinogen levels to 120 mg/dL and a decrease in PT to 18 seconds. However, her hemoglobin remains critically low at 7.0 g/dL, emphasizing the ongoing need for vigilance in managing her blood loss and preventing further anemia. Despite this, the patient's hemodynamics show slight improvement with a heart rate stabilizing at 110 beats per minute, though her blood pressure remains on the lower side at 90/50 mmHg, necessitating continued low-dose vasopressor support.

The patient's respiratory status, however, poses a significant challenge. Despite supplemental oxygen and bicarbonate administration, her oxygen saturation hovers around 88-90%, and she exhibits tachypnea with a respiratory rate of 28 breaths per minute. A chest X-ray is ordered, revealing bilateral infiltrates consistent with early Acute Respiratory Distress Syndrome (ARDS), likely secondary to the underlying DIC and possible fluid overload. The decision is made to transfer the patient to a high-frequency oscillatory ventilation to optimize her oxygenation without exacerbating barotrauma.

These developments demand heightened clinical reasoning from the team as they balance the risks of fluid management against the need for aggressive respiratory support. Continuous monitoring for signs of multi-organ dysfunction, particularly renal impairment, becomes imperative as the team assesses her urine output, which has decreased to 20 mL/hour, and her creatinine level, which has risen to 1.8 mg/dL. The team prepares for potential renal support interventions while maintaining a delicate equilibrium in fluid and hemodynamic management, ensuring that each decision is tailored to the evolving complexities of the patient's condition.

Section 5

As the medical team continues to navigate the complexities of the patient's condition, a new complication emerges that demands immediate attention. The patient's urine output has further decreased, now measuring only 10 mL/hour, raising concerns about acute kidney injury. Her creatinine level has climbed to 2.5 mg/dL, indicating a significant decline in renal function. This development prompts the nephrology team to be consulted for possible initiation of renal replacement therapy, such as continuous renal replacement therapy (CRRT), to manage her fluid balance and prevent further renal deterioration.

Simultaneously, the patient's hemodynamic status presents another critical challenge. Despite ongoing vasopressor support, her blood pressure has dropped to 85/45 mmHg, and her heart rate has increased to 120 beats per minute. The addition of a second vasopressor is contemplated to maintain adequate perfusion to vital organs. Clinicians must carefully assess the risk of exacerbating her fluid overload while ensuring sufficient circulatory support. The team considers adjusting her fluid management strategy, potentially incorporating albumin to improve intravascular volume without overwhelming her compromised respiratory system.

The patient's respiratory condition remains precarious, with her oxygen saturation persistently low at 86-88% despite high-frequency oscillatory ventilation. The team debates the potential benefits and risks of transitioning to extracorporeal membrane oxygenation (ECMO) to provide more effective oxygenation support. This decision requires a thorough evaluation of the patient's overall stability and the likelihood of recovery from ARDS, weighing the invasive nature of ECMO against the current trajectory of her respiratory failure. The multidisciplinary team continues to collaborate closely, incorporating these new challenges into their ongoing management strategy, striving to stabilize the patient in the face of evolving complications.